{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:28:05Z","timestamp":1762504085014},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T00:00:00Z","timestamp":1456272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJEM"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S1481803516000075_abs1\" sec-type=\"objectives\"><jats:title>Objectives<\/jats:title><jats:p>Bronchiolitis is the leading cause of hospital admission for infants, but few studies have examined management of this condition in community hospital settings. We reviewed the management of children with bronchiolitis presenting to community hospitals in Ontario.<\/jats:p><\/jats:sec><jats:sec id=\"S1481803516000075_abs2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>We retrospectively reviewed a consecutive cohort of infants less than 12 months old with bronchiolitis who presented to 28 Ontario community hospitals over a two-year period. Bronchiolitis was defined as first episode of wheezing associated with signs of an upper respiratory tract infection during respiratory syncytial virus season.<\/jats:p><\/jats:sec><jats:sec id=\"S1481803516000075_abs3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>Of 543 eligible children, 161 (29.7%, 95% Confidence Interval (CI) 22.3 to 37.0%) were admitted to hospital. Hospital admission rates varied widely (Interquartile Range 0%-40.3%). Bronchodilator use was widespread in the emergency department (ED) (79.7% of patients, 95% CI 75.0 to 84.5%) and on the inpatient wards (94.4% of patients, 95% CI 90.2 to 98.6%). Salbutamol was the most commonly used bronchodilator. At ED discharge 44.7% (95% CI 37.5 to 51.9%) of patients were prescribed a bronchodilator medication. Approximately one-third of ED patients (30.8%, 95% CI 22.7 to 38.8%), 50.3% (95% CI 37.7 to 63.0%) of inpatients, and 23.5% (95% CI 14.4 to 32.7) of patients discharged from the ED were treated with corticosteroids. The most common investigation obtained was a chest x-ray (60.2% of all children; 95% CI 51.9 to 68.5%).<\/jats:p><\/jats:sec><jats:sec id=\"S1481803516000075_abs4\" sec-type=\"conclusions\"><jats:title>Conclusions<\/jats:title><jats:p>Infants with bronchiolitis receive medications and investigations for which there is little evidence of benefit. This suggests a need for knowledge translation strategies directed to community hospitals.<\/jats:p><\/jats:sec>","DOI":"10.1017\/cem.2016.7","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T09:48:23Z","timestamp":1456307303000},"page":"443-452","source":"Crossref","is-referenced-by-count":12,"title":["Management of Bronchiolitis in Community Hospitals in Ontario: a Multicentre Cohort Study"],"prefix":"10.1007","volume":"18","author":[{"given":"Amy C.","family":"Plint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Taljaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice","family":"McGahern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon D.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy M.","family":"Grimshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry P.","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,24]]},"reference":[{"key":"S1481803516000075_ref29","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.196"},{"key":"S1481803516000075_ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2010.00699.x"},{"key":"S1481803516000075_ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2004.tb01452.x"},{"key":"S1481803516000075_ref13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.6.1789"},{"key":"S1481803516000075_ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.152.8.739"},{"key":"S1481803516000075_ref25","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/19.9.485"},{"key":"S1481803516000075_ref19","first-page":"CD001266","article-title":"Bronchodilators for bronchiolitis","author":"Kellner","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"S1481803516000075_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(93)90050-B"},{"key":"S1481803516000075_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.05.021"},{"key":"S1481803516000075_ref24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2742"},{"key":"S1481803516000075_ref31","first-page":"CD001279","article-title":"Anticholinergic drugs for wheeze in children under the age of two years","volume":"1","author":"Everard","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"S1481803516000075_ref26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.4.e49"},{"key":"S1481803516000075_ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900544"},{"key":"S1481803516000075_ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.pec.0000161469.19841.86"},{"key":"S1481803516000075_ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.15.1440"},{"key":"S1481803516000075_ref38","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-0655"},{"key":"S1481803516000075_ref34","first-page":"CD001955","article-title":"Glucocorticoids for croup","volume":"1","author":"Russell","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"S1481803516000075_ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-011-1653-9"},{"key":"S1481803516000075_ref37","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-2005"},{"key":"S1481803516000075_ref1","first-page":"65","volume-title":"Respiratory disease in Canada","author":"Njoo","year":"2001"},{"key":"S1481803516000075_ref28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.4.e44"},{"key":"S1481803516000075_ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.156.11.1086"},{"key":"S1481803516000075_ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2003.00069.x"},{"key":"S1481803516000075_ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1714"},{"key":"S1481803516000075_ref11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.104.6.1334"},{"key":"S1481803516000075_ref35","first-page":"CD000060","article-title":"Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children","author":"Plotnick","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"S1481803516000075_ref30","first-page":"547","article-title":"Oral salbutamol for symptomatic relief in mild bronchiolitis a double blind randomized placebo controlled trial","volume":"45","author":"Gupta","year":"2008","journal-title":"Indian Pediatr"},{"key":"S1481803516000075_ref17","doi-asserted-by":"publisher","DOI":"10.2307\/1403259"},{"key":"S1481803516000075_ref21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-2223"},{"key":"S1481803516000075_ref33","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1299"},{"key":"S1481803516000075_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ambp.2007.03.006"},{"key":"S1481803516000075_ref27","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.1982"},{"key":"S1481803516000075_ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.157.10.957"},{"key":"S1481803516000075_ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.154.10.997"},{"key":"S1481803516000075_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.01.005"},{"key":"S1481803516000075_ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199308000-00007"},{"key":"S1481803516000075_ref39","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-1427m"},{"key":"S1481803516000075_ref2","doi-asserted-by":"publisher","DOI":"10.1086\/379740"},{"key":"S1481803516000075_ref3","volume-title":"Monitoring the Health of New Zealand Children and Young People: Indicator Handbook","author":"Craig","year":"2007"},{"key":"S1481803516000075_ref41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-12-171"},{"key":"S1481803516000075_ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301839"}],"container-title":["CJEM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1481803516000075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T23:38:37Z","timestamp":1609457917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1481803516000075\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,24]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1481803516000075"],"URL":"https:\/\/doi.org\/10.1017\/cem.2016.7","relation":{},"ISSN":["1481-8035","1481-8043"],"issn-type":[{"value":"1481-8035","type":"print"},{"value":"1481-8043","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,24]]}}}